Clinical Trial Update: A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anakinra to prevent or treat severe side effects in patients receiving CAR-T cell therapy; status is active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: B Cell ALL, B-Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING